Botulinum Toxin: The Hopeful Prospects for Treating Prostate Cancer
DOI:
https://doi.org/10.46966/msjar.v6i4.331Keywords:
Botulinum Toxin, Prostate Cancer, BTX-A injectionAbstract
It has been demonstrated that peripheral nerves influence the development and metastasis of prostate tumors by supplying nourishment to the stroma and cancer cells within the tumor environment. The impact of botulinum toxin (BT) on prostate tumor tissue has been documented in a number of in vitro and in vivo investigations. Human BT has been shown to induce cancer cell death, resulting in morphological alterations that include large atrophic and degenerative cancerous regions, decreased pyknotic nuclei and cytoplasm compared to cancer tissues injected with saline Experimental, epidemiological, and clinical evidence showing the impact of BT in the management of prostate cancer has been produced using this body of knowledge about physiology and pathology. This suggests a potent treatment plan , that would lower prostate cancer mortality.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Marwa H. Almuhammady, Zahraa Abdul-Hussain Al-Zahraa Abdul-Hussain AL-Moomen, Sarah Ali Aljazaeri
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
